Search research articles
Contact Us
Filters
Showing results (231-240 of 280) with videos related to
Page
of 28
Sort By:
International Journal of Molecular Medicine
|
February 9, 2006
Gene expression in mouse spermatogenesis during ontogenesis
Vincenza Giuffrida, Franca Maria Pezzino, Fabrizio Romano, et al.
Advances in Biological Regulation
|
June 5, 2018
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
William H Chappell, Saverio Candido, Stephen L Abrams, et al.
Molecular Cancer Therapeutics
|
May 7, 2009
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt
Danijela Maksimovic-Ivanic, Sanja Mijatovic, Djordje Miljkovic, et al.
Nitric Oxide : Biology and Chemistry
|
May 8, 2008
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells
Sanja Mijatovic, Danijela Maksimovic-Ivanic, Marija Mojic, et al.
International Journal of Oncology
|
January 11, 2019
Cancer-associated stroke: Pathophysiology, detection and management (Review)
Efthimios Dardiotis, Athina-Maria Aloizou, Sofia Markoula, et al.
Expert Opinion on Emerging Drugs
|
September 1, 2009
Emerging Raf inhibitors
James A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Expert Opinion on Emerging Drugs
|
February 16, 2010
Emerging MEK inhibitors
James A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Advances in Biological Regulation
|
October 10, 2017
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals
James A McCubrey, Stephen L Abrams, Kvin Lertpiriyapong, et al.
Journal of Cellular Physiology
|
February 9, 2011
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways
James A McCubrey, Linda S Steelman, C Ruth Kempf, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 2, 2021
Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme
Michele Stella, Luca Falzone, Angela Caponnetto, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 280) with videos related to
Sort By:
Page
of 28
International Journal of Molecular Medicine
|
February 9, 2006
Gene expression in mouse spermatogenesis during ontogenesis
Vincenza Giuffrida, Franca Maria Pezzino, Fabrizio Romano, et al.
Advances in Biological Regulation
|
June 5, 2018
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
William H Chappell, Saverio Candido, Stephen L Abrams, et al.
Molecular Cancer Therapeutics
|
May 7, 2009
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt
Danijela Maksimovic-Ivanic, Sanja Mijatovic, Djordje Miljkovic, et al.
Nitric Oxide : Biology and Chemistry
|
May 8, 2008
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells
Sanja Mijatovic, Danijela Maksimovic-Ivanic, Marija Mojic, et al.
International Journal of Oncology
|
January 11, 2019
Cancer-associated stroke: Pathophysiology, detection and management (Review)
Efthimios Dardiotis, Athina-Maria Aloizou, Sofia Markoula, et al.
Expert Opinion on Emerging Drugs
|
September 1, 2009
Emerging Raf inhibitors
James A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Expert Opinion on Emerging Drugs
|
February 16, 2010
Emerging MEK inhibitors
James A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Advances in Biological Regulation
|
October 10, 2017
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals
James A McCubrey, Stephen L Abrams, Kvin Lertpiriyapong, et al.
Journal of Cellular Physiology
|
February 9, 2011
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways
James A McCubrey, Linda S Steelman, C Ruth Kempf, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 2, 2021
Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme
Michele Stella, Luca Falzone, Angela Caponnetto, et al.
Page
of 28